- The Efficacy of Vildagliptin in Korean Patients with Type 2 Diabetes
-
Moon JS, Won KC
- KMID: 2280740
- Diabetes Metab J.
- 2013 Feb;37(1):36-39.
- doi: 10.4093/dmj.2013.37.1.36
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of DPP-4 Inhibitors
-
Kim NH, Kim SG
- KMID: 2173918
- J Korean Diabetes.
- 2013 Sep;14(3):111-119.
- doi: 10.4093/jkd.2013.14.3.111
During past several years, a novel class of antihyperglycemic agents, dipeptidyl peptidase-4 (DPP-4) inhibitors, has become one of the most important options in the management of type 2 diabetes. These... -
- CITED
-
- Close
- SHARE
-
- Close
- New Therapeutics for Diabetes Using Incretin Hormone
-
Oh S
- KMID: 2259281
- Korean J Med.
- 2011 Jun;80(6):625-634.
New therapeutics for type 2 diabetes using incretin hormone were introduced recently. Incretin-based therapies consist of two types: GLP-1 agonists mainly acting on the GLP-1 receptor and dipeptidyl peptidase 4... -
- CITED
-
- Close
- SHARE
-
- Close
- Incretin-based Combination Therapy in Type 2 Diabetes Mellitus
-
Kim JH, Lee MS
- KMID: 2188084
- J Korean Med Assoc.
- 2009 Oct;52(10):1030-1036.
- doi: 10.5124/jkma.2009.52.10.1030
While there are many therapies for type 2 diabetes are available including insulin secretagogues, insulin sensitizers and exogenous insulin, many patients are unable to reach recommended therapeutic targets. Incretin-based therapies... -
- CITED
-
- Close
- SHARE
-
- Close
- Predictive Clinical Parameters and Glycemic Efficacy of Vildagliptin Treatment in Korean Subjects with Type 2 Diabetes
-
Chang JS, Shin J, Kim HS, Kim KH, Shin JA, Yoon KH, Cha BY, Son HY, Cho JH
- KMID: 2280745
- Diabetes Metab J.
- 2013 Feb;37(1):72-80.
- doi: 10.4093/dmj.2013.37.1.72
BACKGROUND: The aims of this study are to investigate the glycemic efficacy and predictive parameters of vildagliptin therapy in Korean subjects with type 2 diabetes. METHODS: In this retrospective study, we... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Vildagliptin-Metformin and Glimepiride-Metformin Treatments in Type 2 Diabetic Patients
-
Jeon HJ, Oh TK
- KMID: 1857509
- Diabetes Metab J.
- 2011 Oct;35(5):529-535.
- doi: 10.4093/dmj.2011.35.5.529
BACKGROUND: The present study investigated the efficacy and safety of vildagliptin-metformin treatment compared to those of glimepiride-metformin treatment for type 2 diabetes. METHODS: In a randomized, open-label, comparative study, 106 patients... -
- CITED
-
- Close
- SHARE
-
- Close
- DPP-4 Inhibitors and the Relations between Rosiglitazone and the Risk of Myocardial Infarction
-
Lee HW
- KMID: 2185748
- J Korean Med Assoc.
- 2008 Apr;51(4):371-376.
- doi: 10.5124/jkma.2008.51.4.371
If the type 2 diabetes is left untreated, it can eventually be lead to vascular complications, including nephropathy, retinopathy, neuropathy, coronary heart disease, and CVA. The current antidiabetic drugs are... -
- CITED
-
- Close
- SHARE
-
- Close
- Electrophysiological Characterization of AMPA and NMDA Receptors in Rat Dorsal Striatum
-
Jeun SH, Cho HS, Kim KJ, Li QZ, Sung KW
- KMID: 2071673
- Korean J Physiol Pharmacol.
- 2009 Jun;13(3):209-214.
- doi: 10.4196/kjpp.2009.13.3.209
The striatum receives glutamatergic afferents from the cortex and thalamus, and these synaptic transmissions are mediated by alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) and N-methyl-D-aspartate (NMDA) receptors. The purpose of this study was to... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Characteristics of the Responders to Dipeptidyl Peptidase-4 Inhibitors in Korean Subjects with Type 2 Diabetes
-
Oh TJ, Jung HS, Bae JH, Kim YG, Park KS, Cho YM, Park KS, Kim SY
- KMID: 2158036
- J Korean Med Sci.
- 2013 Jun;28(6):881-887.
- doi: 10.3346/jkms.2013.28.6.881
We investigated characteristics associated with the efficacy of dipeptidyl peptidase-4 inhibitors (DPP4i) in Korean patients with type 2 diabetes. We reviewed medical records of 477 patients who had taken sitagliptin... -
- CITED
-
- Close
- SHARE
-
- Close
